Several factors make ovarian cancer particularly challenging to treat. This is largely because the cancer often spreads at a microscopic level within the abdomen early on, resulting in diagnosis at an advanced stage. Additionally, ...
Oct 1, 2025
0
0
Chimeric antigen receptor (CAR) T cell therapy, which uses a patient's own immune cells to fight cancer, has emerged as a powerful way to treat lymphoma and other blood cancers. But researchers have struggled to adapt the ...
Oct 1, 2025
0
63
Ovarian cancer is known for its aggressive spread, often targeting fatty tissues in the abdomen. Now, a study published in Nature Communications by researchers at Karolinska Institutet and Queen Mary University of London ...
Sep 30, 2025
0
46
Breast cancer remains the most common cancer and the leading cause of cancer-related death among women worldwide, with incidence rates continuing to rise. However, known risk factors, including genetics and lifestyle, do ...
Sep 22, 2025
0
0
The incidence of obesity-associated cancers in Puerto Rico rose significantly between 2000 and 2022, according to research presented at the 18th AACR Conference on the Science of Cancer Health Disparities, held September ...
Sep 19, 2025
0
0
Ovarian cancer is relatively rare. However, it's often fatal in later stages of the disease. The cancer begins in the ovaries and spreads to the abdomen and pelvis if it isn't diagnosed and treated early. It primarily affects ...
Sep 17, 2025
0
0
Researchers from Queen Mary University of London have developed and validated a new tool that could help GPs detect ovarian cancer earlier and improve patient outcomes cost-effectively.
Sep 17, 2025
0
0
A UNSW Sydney researcher says narrowing women's health to "bikini medicine"—issues that occur between the breasts and the pubic bone—has left women underserved in nearly every other area of health, including disease, ...
Sep 10, 2025
0
0
New research by Wistar Institute scientists shows how targeting a cleft in the retinoblastoma protein can kill tumor-protecting macrophages in ovarian cancer. The discovery provides a novel therapeutic target that could potentially ...
Sep 9, 2025
0
5
Research led by the Indiana University School of Medicine and the University of Florida reports an association between taking GLP-1 receptor agonists and lower overall cancer risk in adults with obesity or overweight, with ...
Ovarian cancer is a cancerous growth arising from the ovary. Symptoms are frequently very subtle early on and may include: bloating, pelvic pain, difficulty eating and frequent urination, and are easily confused with other illnesses.
Most (more than 90%) ovarian cancers are classified as "epithelial" and are believed to arise from the surface (epithelium) of the ovary. However, some evidence suggests that the fallopian tube could also be the source of some ovarian cancers. Since the ovaries and tubes are closely related to each other, it is thought that these fallopian cancer cells can mimic ovarian cancer. Other types may arise from the egg cells (germ cell tumor) or supporting cells. These cancers are grouped into the category of gynecologic cancer.
This text uses material from Wikipedia licensed under CC BY-SA
